BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China flag China · Delayed Price · Currency is CNY
27.03
-0.86 (-3.08%)
At close: Nov 17, 2026

SHA:688166 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11,76420,74012,74814,7869,53515,051
Market Cap Growth
-49.26%62.70%-13.79%55.07%-36.65%-19.85%
Enterprise Value
13,32122,55814,39115,98310,60615,560
Last Close Price
27.8949.0430.1434.8422.3536.15

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
112.24380.4467.3973.0339.7961.70
Forward PE
-82.4552.9828.0028.0043.06
PS Ratio
9.0416.959.9412.549.3714.30
PB Ratio
3.937.295.256.124.258.64
P/TBV Ratio
4.038.495.576.524.549.47
P/OCF Ratio
28.2163.7851.9175.9230.6385.48

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
10.2018.4311.2213.5510.4314.79
EV/EBITDA Ratio
45.89115.6048.2858.1139.1354.92
EV/EBIT Ratio
129.35437.4971.6876.7545.8462.45

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.740.840.920.910.900.52
Debt / EBITDA Ratio
8.5311.437.167.717.173.10
Debt / FCF Ratio
16.72-----
Net Debt / Equity Ratio
0.350.500.610.480.350.32
Net Debt / EBITDA Ratio
4.217.354.934.212.921.99
Net Debt / FCF Ratio
7.86-11.18-126.33-5.54-1.90-0.77
Asset Turnover
0.230.220.250.240.270.44
Inventory Turnover
1.791.691.581.741.632.33
Quick Ratio
1.481.021.061.491.921.23
Current Ratio
1.901.401.562.002.391.70
Return on Equity (ROE)
3.49%1.40%5.83%7.44%10.62%14.97%
Return on Assets (ROA)
1.11%0.59%2.46%2.69%3.79%6.49%
Return on Invested Capital (ROIC)
2.27%1.26%4.83%5.79%7.57%13.37%
Return on Capital Employed (ROCE)
2.00%1.10%4.90%5.10%6.00%10.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
0.89%0.26%1.48%1.37%2.51%1.62%
FCF Yield
1.25%-0.62%-0.09%-1.41%-4.36%-4.87%
Dividend Yield
0.06%0.03%0.32%0.27%0.51%0.33%
Payout Ratio
99.44%215.73%71.75%56.80%41.77%22.26%
Buyback Yield / Dilution
-1.58%0.24%0.34%-2.10%-1.61%1.87%
Total Shareholder Return
-1.52%0.28%0.66%-1.82%-1.11%2.20%